| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50042 |
C3H/MCA clone 15 |
mouse |
embryo |
Parent strain is C3H/10T/1/2 clone 8. |
|
| 2 | general cells |
IFO50283 |
IMR-32 |
human |
|
Human nueroblastoma cell line. |
|
| 3 | general cells |
IFO50315 |
RMG-I |
human |
ovary |
clear cell carcinoma |
|
| 4 | general cells |
IFO50320 |
RMUG-S |
human |
ovary |
mucinous cystadenocarcinoma |
|
| 5 | general cells |
IFO50373 |
TKC2 |
mouse |
kidney |
cAMP synthesis is stimulated by arginine vasopressin in the cells. Growth temperature is 33 C. |
|
| 6 | general cells |
IFO50483 |
CCD-33Co |
human |
colon |
Human fibroblast cell line established from normal colon. The ampoules preserved in the cell bank hardly proliferate. |
|
| 7 | general cells |
JCRB0003 |
C3H/10T1/2-clone 8 |
mouse |
embryo |
fibroblast, contact inhibited, (C3H mouse) |
|
| 8 | general cells |
JCRB0033 |
CCRF-CEM |
human |
peripheral blood (buffy coat) |
leukemia, acute T lymphoblastic |
|
| 9 | general cells |
JCRB0199 |
huH-1 |
human |
liver |
Human hepatoma cell line. |
|
| 10 | general cells |
JCRB0221 |
HT100 |
hamster, Syrian |
lung |
lung, new born |
|
| 11 | general cells |
JCRB0233.0 |
BALB-MC |
mouse |
mammary gland |
mammary cancer, (BALB/cHe mouse) |
|
| 12 | general cells |
JCRB0521 |
MRC-5-30 |
human |
fetus lung |
fetal lung, normal diploid fibroblast, PDL=about 30 |
|
| 13 | general cells |
JCRB0543 |
TIG-110 |
human |
skin |
Normal diploid fibroblast from human skin with limited lifespan. |
|
| 14 | general cells |
JCRB0608 |
JTC19 |
rat |
lung |
lung, (JAR-1 rat) |
|
| 15 | general cells |
JCRB0718.1 |
RLC-10.P3 |
rat |
liver |
Rat normal cell line cultured with serum free medium for long passages. |
|
| 16 | general cells |
JCRB0721 |
F9 |
mouse |
testis (transplanted with embryo) |
teratocarcinoma, differentiation-inducible, (129/Sv mouse) |
|
| 17 | general cells |
JCRB0741 |
NG-3Y1-T6R |
rat |
embryo/fetus whole body |
3Y1 derivative, transformed by MNNG, (Fischer rat) |
|
| 18 | general cells |
JCRB1012 |
KMRC-3 |
human |
kidney |
Human tumor cell line from kidney. Clear cell renal carcinoma cell line. The growth is extremely slow. |
|
| 19 | general cells |
JCRB1033 |
NOZ |
human |
ascites |
Human gallbladder carcinoma cell line. |
|
| 20 | general cells |
JCRB1091 |
NCE SVIIA3 |
human |
cervix |
SV40 transformed keratinocyte cells derived from human cervix. |
|
| 21 | general cells |
JCRB1192 |
KMS-28BM |
human |
bone marrow |
human myeloma cell line. |
|
| 22 | general cells |
JCRB1222.04 |
HGH1.35.2 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
| 23 | general cells |
JCRB1301 |
SC78.H81.C81.A9 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against scopolamine. |
|
| 24 | general cells |
JCRB1325 |
MKPL-1 |
human |
bone marrow |
A megakaryoblastic leukemia cell line from human acute myeloblastic leukemia. |
|
| 25 | general cells |
JCRB1358.04 |
SRBC-F12-1-19 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
| 26 | general cells |
JCRB1358.09 |
SRBC-RP8-2-4 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
| 27 | general cells |
JCRB1422 |
KYSE850 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 28 | general cells |
JCRB1439 |
KYSE520 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 29 | general cells |
JCRB1456 |
KYSE1240 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 30 | general cells |
JCRB1483 |
KYAE-1 |
human |
Pleyral effusion |
Human esophageal adenocarcinoma cell line. |
|
| 31 | general cells |
JCRB1539 |
HAC-2 |
human |
ascites |
Human ovary cancer cell line derived from mesonephros. |
|
| 32 | general cells |
JCRB1621 |
hTf2-9F/sf |
mouse x mouse |
|
This cell line produce monoclonal antibody against human transferrin. |
|
| 33 | general cells |
JCRB1642 |
KMS-11/BTZ |
human |
pleural effusion |
bortezomib-resistant multiple myeloma cell line. |
|
| 34 | general cells |
JCRB1795 |
BALM-16 |
human |
peripheral blood |
B cell leukemia cell line, Ig negative, ALL-L3 cell line, t(8;22)(q24;q11), hypercalcemia, mRNA expression of PTHrP |
|
| 35 | general cells |
JCRB1800 |
BALM-23 |
human |
bone marrow |
B cell leukemia cell line, ALL-L2 cell line, hypercalcemia |
|
| 36 | general cells |
JCRB1820 |
MOLP-2 |
human |
peripheral bood |
Multiple myeloma-derived cell line. IL-6 receptor(+), CD28(+), CD33(+), IgD ramda(+) (Growth is extremely slow, DT = 1 week.) |
|
| 37 | general cells |
JCRB1823 |
NALM-20 |
human |
peripheral bood |
Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line. |
|
| 38 | general cells |
JCRB1930 |
Me2Tu |
human |
|
Transplanted cell line of malignant pleural mesothelioma TCC-MESO-2 into SCID mice. |
|
| 39 | general cells |
JCRB2210 |
A9(Bsr10) |
human chromosome-introduced |
skin |
contains human chromosome #10 (MTA with Tottori Univ. is required.) |
|
| 40 | general cells |
JCRB2212 |
A9(Neo12) |
human chromosome-introduced |
skin |
contains human chromosome #12 (MTA with Tottori Univ. is required.) |
|
| 41 | general cells |
JCRB4074 |
UT-7/TPO |
human |
bone marrow |
A subline of UT-7 with absolute dependence on thrombopoietin (TPO) for growth and survival |
|
| 42 | general cells |
JCRB4081 |
NCC-GCTB5-C1 |
human |
Right proximal tibia |
Giant cell tumor cell line |
|
| 43 | general cells |
JCRB4084 |
UT-7 |
human |
bone marrow |
Human megakaryoblastic leukemia cell line with absolute dependence on interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor
(GM-CSF), or erythropoietin (EPO) for growth and survival. |
|
| 44 | general cells |
JCRB4116 |
NCC-CS1-C1 |
human |
Chest |
Chondrosarcoma cell line derived from conventional central grade 3 CS. |
|
| 45 | general cells |
JCRB4143 |
NCC-SS3-C1 |
human |
Left upper arm |
synovial sarcoma cell line |
|
| 46 | general cells |
JCRB4157 |
NCC-CDS2-C1 |
human |
Left thigh |
CIC rearranged sarcoma cell line |
|
| 47 | general cells |
JCRB9019 |
3T3-Swiss albino |
mouse |
embryo |
fibroblast, contact inhibited, (Swiss albino mouse) |
|
| 48 | general cells |
JCRB9029 |
MDCK (NBL-2) |
dog |
kidney |
established from normal kidney, susceptible for many viral species |
|
| 49 | general cells |
JCRB9087 |
RPMI 1846 |
hamster, Syrian |
melanotic melanoma |
melanotic melanoma |
|
| 50 | general cells |
JCRB9093 |
WEHI-3 |
mouse |
peripheral blood |
leukemia, myelomonocytic, macrophage-like, (BALB/c mouse) |
|
| 51 | general cells |
JCRB9094 |
DLD-1 |
human |
colon |
adenocarcinoma |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.